Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MIF | P14174 | 1/20 | 0.68 |
| ▸ | TYR | P14679 | 3/20 | 0.67 |
| ▸ | CHRNA7 | P36544 | 7/20 | 0.66 |
| ▸ | CA1 | P00915 | 2/20 | 0.60 |
| ▸ | CA2 | P00918 | 2/20 | 0.60 |
| ▸ | CA4 | P22748 | 2/20 | 0.60 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.60 |
| ▸ | BACE1 | P56817 | 1/20 | 0.60 |
| ▸ | MGAM | O43451 | 1/20 | 0.56 |
| ▸ | GAA | P10253 | 1/20 | 0.56 |
| ▸ | SI | P14410 | 1/20 | 0.56 |
| ▸ | MGAM2 | Q2M2H8 | 1/20 | 0.56 |
| ▸ | CA12 | O43570 | 1/20 | 0.53 |
| ▸ | AKR1B10 | O60218 | 1/20 | 0.53 |
| ▸ | ESR1 | P03372 | 1/20 | 0.53 |
| ▸ | CA3 | P07451 | 1/20 | 0.53 |
| ▸ | PKM | P14618 | 1/20 | 0.53 |
| ▸ | AKR1B1 | P15121 | 1/20 | 0.53 |
| ▸ | CA6 | P23280 | 1/20 | 0.53 |
| ▸ | DPP4 | P27487 | 1/20 | 0.53 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28391865 | 1.00 | MIF (0.68) | MIFTYRCHRNA7CA1CA2 | |
| SCHEMBL89187 | 1.00 | MIF (0.68) | MIFTYRCHRNA7CA1CA2 | |
| SCHEMBL28140874 | 1.00 | MIF (0.68) | MIFTYRCHRNA7CA1CA2 | |
| SCHEMBL11461920 | 0.98 | MIF (0.66) | MIFTYRCHRNA7CA1CA2 | |
| SCHEMBL27576656 | 0.98 | MIF (0.66) | MIFTYRCHRNA7CA1CA2 | |
| SCHEMBL29065212 | 0.93 | CHRNA7 (0.61) | MIFTYRCHRNA7CA1CA2 | |
| SCHEMBL29065213 | 0.93 | CHRNA7 (0.61) | MIFTYRCHRNA7CA1CA2 | |
| Coumaric Acid SCHEMBL28848354 | 0.91 | BACE1 (0.74) | MIFTYRCHRNA7CA1CA2 | |
| SCHEMBL4653698 | 0.86 | CHRNA7 (0.68) | TYRCHRNA7NFKB1BACE1MGAM | |
| SCHEMBL4653701 | 0.86 | CHRNA7 (0.68) | TYRCHRNA7NFKB1BACE1MGAM |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1144 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250295113-A1 | COMPOSITION AND METHOD FOR CONTROLLING WEEDS | SYNGENTA CROP PROTECTION AG (CH) | 2025-09-25 | — | — | US | claimed |
| EP-4615506-A1 | USE OF GSK-3 ACTIVATIOR TO MODULATE PROTEASOME ACTIVITY TO PREVENT AGEING ASSOCIATED CONDITIONS AND DISEASES | Sahin, Fikret (TR) | 2025-09-17 | — | — | EP | claimed |
| US-12391981-B2 | Chromogenic peroxidase substrates | AGILENT TECHNOLOGIES, INC. (US) | 2025-08-19 | — | — | US | claimed |
| WO-2025081932-A1 | RETINOL DERIVATIVE OR SALT THEREOF, AS WELL AS PREPARATION METHOD THEREFOR AND USE THEREOF | 深圳市护家科技有限公司 | 2025-04-24 | — | — | WO | claimed |
| EP-4521930-A1 | COMPOSITION AND METHOD FOR CONTROLLING WEEDS | Syngenta Crop Protection AG (CH) | 2025-03-19 | — | — | EP | claimed |
| CN-119640034-A | Rare earth leaching agent and application thereof | 清华大学 | 2025-03-18 | — | — | CN | claimed |
| CN-119438415-A | Method for measuring content of triterpenic acid compounds in poria cocos and application of method | 湖南中医药大学 | 2025-02-14 | — | — | CN | claimed |
| WO-2025024478-A1 | COMPOSITIONS FOR THE MODULATION OF TASTE | IXORA SCIENTIFIC INC. (US) | 2025-01-30 | — | — | WO | claimed |
| WO-2025005092-A1 | TREATMENT SOLUTION, METHOD FOR TREATING OBJECT, AND METHOD FOR PRODUCING SEMICONDUCTOR DEVICE | 富士フイルム株式会社 | 2025-01-02 | — | — | WO | claimed |
| WO-2024258363-A1 | USE OF GSK-3 ACTIVATIOR TO MODULATE PROTEASOME ACTIVITY TO PREVENT AGEING ASSOCIATED CONDITIONS AND DISEASES | SAHIN FIKRET (TR) | 2024-12-19 | — | — | WO | claimed |
| EP-0737228-B2 | ETHYLENE-ALPHA-OLEFIN BELTING | GATES RUBBER CO (US) | 2007-12-12 | — | — | EP | claimed |
| US-20070166251-A1 | Composition and method for treating hyperpigmented skin | LIPO CHEMICALS INC. (US) | 2007-07-19 | — | — | US | claimed |
| EP-1448618-B1 | MELT STRENGTH THERMOPLASTIC ELASTOMERS AND METHODS FOR MAKING SAME | SOLVAY ENGINEERED POLYMERS INC (US) | 2006-03-15 | — | — | EP | claimed |
| CN-1612899-A | Melt strength thermoplastic elastomers and methods for making same | SOLVAY ENGINEERED POLYMERS (US) | 2005-05-04 | — | — | CN | claimed |
| CN-1081654-C | Ethylene-alpha-olefin belting | GATES RUBBER CO (US) | 2002-03-27 | — | — | CN | claimed |
| WO-2000069282-A1 | MODIFICATION OF THE TASTE AND PHYSICOCHEMICAL PROPERTIES OF NEOTAME USING HYDROPHOBIC ACID ADDITIVES | THE NUTRASWEET COMPANY (US) | 2000-11-23 | — | — | WO | claimed |
| CN-1139943-A | Ethylene-alpha-olefin belting | GATES RUBBER CO (US) | 1997-01-08 | — | — | CN | claimed |
| EP-0514467-B1 | COMPOSITIONS AND METHODS FOR INHIBITING BROWNING IN FOODS | OPTA FOOD INGREDIENTS INC (US) | 1994-08-10 | — | — | EP | claimed |
| EP-0514467-A1 | COMPOSITIONS AND METHODS FOR INHIBITING BROWNING IN FOODS. | OPTA FOOD INGREDIENTS INC (US) | 1992-11-25 | — | — | EP | claimed |
| WO-1991011119-A1 | COMPOSITIONS AND METHODS FOR INHIBITING BROWNING IN FOODS | OPTA FOOD INGREDIENTS, INC. (US) | 1991-08-08 | — | — | WO | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070166251-A1 | Composition and method for treating hyperpigmented skin | MMS19, CUTA, FAM20C | MIF 2511/4885TYR 156/4885CHRNA7 4735/4885 |
| US-12391981-B2 | Chromogenic peroxidase substrates | MPO, TPO, TYR | MIF 3676/4885TYR 3/4885CHRNA7 1425/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.